Klingenstein Fields & Co. LP Raises Holdings in Amgen Inc. (NASDAQ:AMGN)
Klingenstein Fields & Co. LP increased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,301 shares of the medical research company’s stock after purchasing an additional 111 shares during the quarter. Klingenstein Fields […]